Division of Discovery Science & Technology (Bioengineering)

This division supports the development of biomedical technologies (without preference for any disease or application) that directly interface with human physiology and control biological function to establish next-generation interventions for human health. This division also supports research to advance the design and deployment of future technology-driven interventions.

Program Area: Prototype Design Cluster

Program Areas: Prototype Demonstration Cluster

Luisa Russell, Ph.D.

Moria Fisher Bittmann, Ph.D.

David Rampulla, Ph.D.

Collaborations

An important aspect of the Institute’s mission is encouraging collaborations among the institutes and centers at NIH, other federal agencies, and the private sector.

  • Interagency Modeling and Analysis Group (IMAG) – IMAG brings together program officers across multiple federal agencies to communicate, disseminate, and plan collaborative activities and joint initiatives related to computational modeling and analysis of biomedical, biological, and behavioral systems. IMAG coordinates the Multi-scale Modeling (MSM) Consortium, see IMAG wiki.
     
  • Synthetic Biology Consortium (SBC) - The SBC is a trans-NIH effort to foster collaborations among researchers and share synthetic biology technologies to address unmet needs in biology and medicine.

Related News

  • NIBIB in the News ·

    As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult. Now, scientists have developed nanoparticles that can break down the physical barriers around tumors to reach cancer cells. Once inside, the nanoparticles release their payload: a gene editing system that alters DNA inside the tumor, blocking its growth and activating the immune system. Source: Science Daily/UT Southwestern Medical Center
  • Science Highlights ·

    An image of the gold nanogrid
    Improvements in brain sensing technologies have allowed clinicians to perform increasingly complex surgeries and enabled researchers to map the signals of the brain that control feeling, movement, and thought.
  • Science Highlights ·

    Microscopy image of regenerated cartilage
    Osteoarthritis – a painful condition that results from the deterioration of the cartilage in our joints – affects millions of people worldwide. To combat this issue, NIBIB-funded researchers are developing an implantable, biodegradable film that helps to regenerate the native cartilage at the site of damage. Their study, performed in rabbits, could be an initial, important step in the establishment of a new treatment.
  • NIBIB in the News ·

    This NIBIB-funded research is focused on creating a new group of nanomaterials designed to capture chemotherapy drugs before they impact healthy tissue. Source: AzoNano
  • Science Highlights ·

    Surgeon holding a probe that is emitting light. Underneath, a chemical compound that is linked to text that reads p28.
    NIBIB-funded researchers are developing an imaging method that would allow surgeons to better identify cancerous cells in breast tumor margins during surgery. This technique could lead to a reduction in follow-up breast cancer surgeries and reduce rates of breast cancer recurrence.